MeiraGTx has announced a strategic collaboration with Johnson & Johnson’s Janssen to develop and commercialise gene therapy treatments for inherited retinal diseases (IRDs).
News
Coeliac UK and Innovate UK team up for coeliac disease solutions
Coeliac UK has combined forces with Innovate UK to drive improvements worth £750,000 in the food technology, diagnostics and digital care industries to provide help for people who need to live gluten free.
Greater Manchester to trial digital service for heart failure
A new digitally-enhanced service for people with heart failure is to be trialled in Greater Manchester, where around 1,000 patients’ data from existing implantable devices will be used to transform care and better meet their needs.
More than £1m available for digital social care projects
Local authorities developing digital social care projects are to be boosted by more than £1 million in Social Care Digital Innovation Programme (SCDIP) funding, provided by NHS Digital and managed by the Local Government Association (LGA).
Cosentyx demand helps drive Novartis’ net sales up 5% in 2018
Novartis has announced a rise of 5% in net sales in 2018, bringing the net total to $51.9 billion.
NHS England unveils five-year deal to expand GP services
NHS England has announced the launch of a new five-year contract for general practice across England, which will see billions of pounds of extra investment for improved access to family doctors, expanded services at local practices and longer appointments for patients who need them.
£1.5million investment in Parkinson’s drug discovery
Parkinson’s UK says it intends to invest a further £1.5 million into its drug discovery programme aiming to develop novel gene transcription modulators for Parkinson’s.
Glasgow groups combine to launch genetic sequencing venture
Four groups based at the University of Glasgow are launching a new venture that will offer a ‘one-stop-shop’ for genetic sequencing for clinicians, researchers, industry partners and the NHS.
ABPI warns over skills shortages
The Association of the British Pharmaceutical Industry is warning that the UK needs to fill an increasing number of science skills gaps in order to retain its prominent position for medicines and vaccines research and development.
NHS England unveils plans to recruit army of social prescribers
NHS England is planning to recruit and ‘army’ of 1,000 social prescribing ‘link workers’ to help alleviate the growing pressure on family doctors.
NICE links with EMIG
The National Institute for Health and Care Excellence and the Ethical Medicines Industry Group (EMIG) are working together to increase understanding of the services the Institute offers the life sciences industry.
Global medicine spend forecast to exceed $1.5 trillion by 2023
A new report containing the latest predictions for the global pharmaceutical market has found that global spending on medicines is set to exceed $1.5 trillion by 2023 – marking a 50% increase within seven years.
Horizon and Rutgers Uni form gene editing partnership
Horizon Discovery and Rutgers University signed a partnership deal to commercialise a new gene editing technology.
FDA approves Imbruvica combination for chronic lymphocytic leukaemia
The FDA has approved AbbVie/Johnson & Johnson’s Imbruvica in combination with Roche’s Gazyva in treatment-naïve patients with chronic lymphocytic leukaemia and small lymphocytic lymphoma (CLL/SLL).
Ultomiris successful in Phase III study
Alexion Pharmaceuticals’ Ultomiris has been found to be successful in treating atypical haemolytic uremic syndrome (aHUS) in a Phase III study.
